ONCY: Another risky biotech to consider

301
Long term downtrend line broken. V shaped upswing with much increased volume. It has a well patented potential product that has great promise in assisting in treatment of difficult cancers. Like all small biotech companies there is often a lot of volatility and risk. I'm looking for a rise to 9-15. Yesterday jump due to Buy rating with target of 15 by HC Wainwright & Co
benzinga.com/stock/oncy

More info at : seekingalpha.com/article/4318241-oncolytics-biotech-small-promising-cancer-player-in-2020

Declinazione di responsabilità

Le informazioni e le pubblicazioni non sono intese come, e non costituiscono, consulenza o raccomandazioni finanziarie, di investimento, di trading o di altro tipo fornite o approvate da TradingView. Per ulteriori informazioni, consultare i Termini di utilizzo.